Reliability of Metformin’s protective effects against doxorubicin-induced cardiotoxicity: a meta-analysis of animal studies

Reliability of Metformin’s protective effects against doxorubicin-induced cardiotoxicity: a meta-analysis of animal studies

BackgroundThe protective effects of metformin (Met) against doxorubicin (Dox)-induced cardiotoxicity via potential hypotheses of mechanisms of action with unknown reliability and credibility.ObjectivesThis study aimed to investigate the protective effects of Met against Dox-induced cardiotoxicity an...

Полное описание

Библиографические подробности
Главные авторы:	Ming-Li Sun, Wei Chen, Xing-He Wang
Формат:	Статья
Язык:	English
Опубликовано:	Frontiers Media S.A. 2024-08-01
Серии:	Frontiers in Pharmacology
Предметы:	animal models Metformin cardioprotective effect DOX-induced cardiotoxicity meta-analysis
Online-ссылка:	https://www.frontiersin.org/articles/10.3389/fphar.2024.1435866/full

Схожие документы

The Protective Effect of Metformin Against Doxorubicin Induced Cardiotoxicity in Rabbits
по: Mohammed Hussein shaty, и др.
Опубликовано: (2019-03-01)

Synergistic cardioprotective effects of melatonin and deferoxamine through the improvement of ferritinophagy in doxorubicin-induced acute cardiotoxicity
по: Mira Hanna, и др.
Опубликовано: (2022-11-01)

Molecular mechanisms associated with the chemoprotective role of protocatechuic acid and its potential benefits in the amelioration of doxorubicin-induced cardiotoxicity: A review
по: Edozie S. Okpara, и др.
Опубликовано: (2022-01-01)

The Role of Flavonoids as a Cardioprotective Strategy against Doxorubicin-Induced Cardiotoxicity: A Review
по: Rony Abdi Syahputra, и др.
Опубликовано: (2022-02-01)

A Novel Berberine–Glycyrrhizic Acid Complex Formulation Enhanced the Prevention Effect to Doxorubicin-Induced Cardiotoxicity by Pharmacokinetic Modulation of Berberine in Rats
по: Shichang Zhang, и др.
Опубликовано: (2022-07-01)

Idebenone alleviates doxorubicin-induced cardiotoxicity by stabilizing FSP1 to inhibit ferroptosis
по: Hongliang Qiu, и др.
Опубликовано: (2024-06-01)

WGX50 mitigates doxorubicin-induced cardiotoxicity through inhibition of mitochondrial ROS and ferroptosis
по: Panpan Tai, и др.
Опубликовано: (2023-11-01)

Demystifying the Relationship Between Metformin, AMPK, and Doxorubicin Cardiotoxicity
по: Manrose Singh, и др.
Опубликовано: (2022-01-01)

Protective effect of coenzyme Q10 against doxorubicin-induced cardiotoxicity: Scoping review article
по: Al Qahtani Abdullah, и др.
Опубликовано: (2024-02-01)

Repeated Remote Ischemic Conditioning Protects Against Doxorubicin Cardiotoxicity
по: Derek J. Hausenloy, MD, PhD, и др.
Опубликовано: (2020-03-01)

Cardioprotection From Cardiotoxicity
по: Guilherme H. Oliveira, MD, MBA
Опубликовано: (2019-09-01)

Nebivolol effect on doxorubicin-induced cardiotoxicity in breast cancer
по: Cochera F, и др.
Опубликовано: (2018-07-01)

The role of hesperidin as a cardioprotective strategy against doxorubicin-induced cardiotoxicity: The antioxidant, anti-inflammatory, antiapoptotic, and cytoprotective potentials
по: Fawiziah K. Alharbi, и др.
Опубликовано: (2023-12-01)

Anthracycline-induced cardiotoxicity – primary preventive options. An overview
по: S. Slavcheva
Опубликовано: (2024-05-01)

Targeting mitochondrial dynamics proteins for the treatment of doxorubicin-induced cardiotoxicity
по: Rui Chen, и др.
Опубликовано: (2023-08-01)

Efficacy and safety of cardioprotective drugs in chemotherapy-induced cardiotoxicity: an updated systematic review & network meta-analysis
по: Ali Mir, и др.
Опубликовано: (2023-02-01)

H3K27ac acts as a molecular switch for doxorubicin-induced activation of cardiotoxic genes
по: Yu Hong, и др.
Опубликовано: (2024-07-01)

Protective Mechanism of Hydrogen Sulfide against Chemotherapy-Induced Cardiotoxicity
по: Shuxu Du, и др.
Опубликовано: (2018-01-01)

Pyridoxamine Limits Cardiac Dysfunction in a Rat Model of Doxorubicin-Induced Cardiotoxicity
по: Sibren Haesen, и др.
Опубликовано: (2024-01-01)

Cellular Mechanisms Mediating Exercise-Induced Protection against Cardiotoxic Anthracycline Cancer Therapy
по: Sanela Dozic, и др.
Опубликовано: (2023-05-01)

Interventions for prevention and treatment of trastuzumab-induced cardiotoxicity: an umbrella review of systematic reviews and meta-analyses
по: Yunfang Wang, и др.
Опубликовано: (2024-12-01)

Natural epigallocatechin-3-gallocarboxylate nanoformulation loaded doxorubicin to construct a novel and low cardiotoxicity chemotherapeutic drug for high-efficiency breast cancer therapy
по: Ke Wang, и др.
Опубликовано: (2024-12-01)

The Essential Strategies to Mitigate Cardiotoxicity Caused by Doxorubicin
по: Aleksey Michailovich Chaulin
Опубликовано: (2023-10-01)

Potential chemoprotective effects of active ingredients in Salvia miltiorrhiza on doxorubicin-induced cardiotoxicity: a systematic review of in vitro and in vivo studies
по: Qingqing Wang, и др.
Опубликовано: (2023-10-01)

Cardioprotective potential of botanical agents against anthracycline-induced cardiotoxicity
по: Parisa Firoozbakhsh, и др.
Опубликовано: (2024-05-01)

Anthracycline-Induced Cardiotoxicity
по: Radomír Hrdina, и др.
Опубликовано: (2000-01-01)

Challenges in the implementation of cardio-oncology trials: lessons learnt from investigating statins in the prevention of anthracycline cardiotoxicity
по: John Lee, и др.
Опубликовано: (2024-12-01)

Interventions for Preventing Cardiotoxicity in Breast Cancer Patients Receiving Trastuzumab: A Systemic Review and Bayesian Network Meta-Analysis
по: Xinyi Li, и др.
Опубликовано: (2021-08-01)

A review of cardioprotective effect of ginsenosides in chemotherapy-induced cardiotoxicity
по: Hadi Zare-Zardini, и др.
Опубликовано: (2024-12-01)

A Comprehensive View on Drugs-Induced Cardiotoxicity and Its Prevention
по: Abdulnaser Ali, и др.
Опубликовано: (2024-03-01)

The Impact of Metformin on the Development of Hypothyroidism and Cardiotoxicity Induced by Cyclophosphamide, Methotrexate, and Fluorouracil in Rats
по: Ahmad H. Alhowail, и др.
Опубликовано: (2023-09-01)

A Review on Effects of Cardiotoxic Drugs in Animal Models
по: Dr. Bader Alsuwayt
Опубликовано: (2021-09-01)

Pharmacological activation of GPX4 ameliorates doxorubicin-induced cardiomyopathy
по: Chuying Huang, и др.
Опубликовано: (2024-04-01)

Efficacy of Neurohormonal Therapies in Preventing Cardiotoxicity in Patients With Cancer Undergoing Chemotherapy
по: Muthiah Vaduganathan, MD, MPH, и др.
Опубликовано: (2019-09-01)

In vivo and in vitro protective effects of shengmai injection against doxorubicin-induced cardiotoxicity
по: Peng Zhou, и др.
Опубликовано: (2022-12-01)

Dapagliflozin May Protect Against Doxorubicin-Induced Cardiotoxicity
по: Sebahat Ulusan, и др.
Опубликовано: (2023-05-01)

Mesenchymal Stem Cell-Derived Exosomes Ameliorate Doxorubicin-Induced Cardiotoxicity
по: Sawdah A. Ali, и др.
Опубликовано: (2024-01-01)

Advantages of prophylactic versus conventionally scheduled heart failure therapy in an experimental model of doxorubicin-induced cardiomyopathy
по: Mária Lódi, и др.
Опубликовано: (2019-07-01)

Cardiovascular Effects of Metformin
по: B. T. Kurmanbekova, и др.
Опубликовано: (2022-03-01)

Nerolidol Attenuates Oxidative Stress, Inflammation, and Apoptosis by Modulating Nrf2/MAPK Signaling Pathways in Doxorubicin-Induced Acute Cardiotoxicity in Rats
по: Seenipandi Arunachalam, и др.
Опубликовано: (2021-06-01)